The inhibitory effect of 15-R-LXA4 on experimental endometriosis
article
OA: closed
CC0
⤵ 14 in-corpus citations
AI-generated summary
This paper investigates the inhibitory effect of 15-R-LXA4 on experimental endometriosis and its underlying mechanisms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo determine the pro-resolution actions of 15-R-LXA(4) (LXA(4)) on endometriotic lesions and on the expression of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) in the murine endometriosis model.Study designIn a prospective, placebo-controlled experimental study, endometriosis was induced in thirty BALB/c mice, and fifteen sham-operated mice served as negative controls. Among the thirty mice with induced endometriosis, fifteen were administered 15-R-LXA(4) and acted as study group (LXA(4) group) and the other fifteen were used as positive controls (EM group). Then all the mice were sacrificed and the endometriotic lesions were weighed. The mRNA and protein levels of IL-1beta and TNF-alpha in the peritoneal fluid were quantified by using real-time polymerase chain reaction (PCR) and enzyme-linked immunoabsorbent assay (ELISA).Result(s)Compared with the positive controls, 15-R-LXA(4) reduced the weight of the endometriotic lesions, decreased the concentrations of IL-1beta and TNF-alpha, and lowered the mRNA levels of IL-1beta and TNF-alpha in peritoneal fluid cells.Conclusion(s)These findings suggest that 15-R-LXA(4) inhibits the progression of endometriosis possibly by suppressing the gene and protein expression of IL-1beta and TNF-alpha.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Basal and cytokine-stimulated production of epithelial neutrophil activating peptide-78 (ENA-78) and interleukin-8 (IL-8) by cultured human endometrial epithelial and stromal cells via openalex
- Concentrations of interleukin (IL)-1α, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis via openalex
- Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis via openalex
- Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment via openalex
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility via openalex
- Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis via openalex
- Integrin-mediated adhesion of uterine endometrial cells from endometriosis patients to extracellular matrix proteins is enhanced by tumor necrosis factor alpha (TNFα) and interleukin-1 (IL-1) via openalex
- New drugs in development for the treatment of endometriosis via openalex
- Ovulation suppression for endometriosis via openalex
- Pathology of endometriosis. via openalex
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin via openalex
- The pathology of endometriosis via openalex
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis via openalex
- Vascular development in endometriosis via openalex
- W2057613504 via openalex
- W2073020365 via openalex
- W2107277218 via openalex
- W1963996841 via openalex
- W2127130381 via openalex
- W1565755899 via openalex
- W2142438877 via openalex
- W2166102027 via openalex
- W4211081176 via openalex
- W2018494885 via openalex
- W6638602116 via openalex
- W2004536682 via openalex
- W1983291636 via openalex
- W1975770623 via openalex
Cited by (15)
- Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model 2022
- Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model 2022
- Effect of Taoren-Quyu decoction on endometriosis in rats 2021
- The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review 2021
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies 2021
- Anti-endometriotic effect of <i>Angelica sinensis</i> (Oliv.) Diels extract in human endometriotic cells and rats 2020
- RhoA/ROCK pathway mediates the effect of oestrogen on regulating epithelial‐mesenchymal transition and proliferation in endometriosis 2020
- Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPk Activation in Endometriosis 2019
- Anti‐Endometriotic Effects of Pueraria Flower Extract in Human Endometriotic Cells and Mice 2017
- Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells 2014
- Therapeutic Potential of Wenshen Xiaozheng Tang, a Traditional Chinese Medicine Prescription, for Treating Endometriosis 2013
- The role of Lipoxin A4 in endometrial biology and endometriosis 2013
- Remission of Endometriosis by Hyperbaric Oxygen Treatment in Rats 2011
- SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model 2010
- Change profiles in matrix metalloproteinase-2 and -9 in induced endometriosis in mice 2010
Source provenance
- europepmc
- last seen: 2026-09-02T07:05:44.937405+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:05.573375+00:00
- unpaywall
- last seen: 2026-09-02T07:26:43.000666+00:00
License: CC0
· commercial use OK